| Literature DB >> 32990891 |
Jennifer Schmidt1, Alexandra Martin2.
Abstract
In biofeedback research, the debate on physiological versus psychological learning has a long tradition and is still relevant today, regarding new developments of biofeedback for behavior modification. Analyzing the role of these learning mechanisms may help improving the protocols and answer the question, whether feedback of physiological functions is necessary to modify a target behavior. We explored the presence and impact of physiological (EEG changes) versus psychological learning (changes in somatic self-efficacy) in a recently developed EEG neurofeedback protocol for binge eating. The protocol targets a reduction of food-cue induced cortical arousal through regulation of EEG high beta activity. In an experimental study accompanying a randomized controlled trial, pre and post treatment EEG measurements were analyzed in a neurofeedback group (n = 18) and an active mental imagery control group without physiological feedback (n = 18). Physiological learning in terms of EEG high beta reduction only occurred in the neurofeedback group. Post treatment, participants with successfully reduced binge eating episodes (≥ 50% reduction) showed lower EEG high beta activity than unsuccessful participants (p = .02) after neurofeedback, but not after mental imagery. Further, lower EEG high beta activity at post-treatment predicted fewer binge eating episodes in neurofeedback only. In mental imagery, somatic self-efficacy predicted treatment success instead of EEG activity. Altogether, the results indicate that physiological changes serve as a specific treatment mechanism in neurofeedback against binge eating. Reducing cortical arousal may improve eating behaviors and corresponding neurofeedback techniques should therefore be considered in future treatments.Entities:
Keywords: Binge eating; Electroencephalography; Neurofeedback; Overeating; Treatment mechanisms
Year: 2020 PMID: 32990891 PMCID: PMC7644525 DOI: 10.1007/s10484-020-09486-9
Source DB: PubMed Journal: Appl Psychophysiol Biofeedback ISSN: 1090-0586
Fig. 1Participant flow according to CONSORT guidelines
Demographic and screening data of the analyzed sample
| Variable | Neurofeedback ( | Mental imagery ( | Total ( | Test statistics |
|---|---|---|---|---|
| Age | 47.94 (14.24) | 39.22 (14.75) | 43.58 (14.96) | |
| Body Mass Index | 27.89 (4.93) | 27.26 (4.86) | 27.58 (4.84) | |
| Restraint score | 19.39 (4.39) | 19.28 (3.97) | 19.33 (4.13) | |
| Eating pathology (EDE-Q total) | 2.19 (0.91) | 2.39 (1.09) | 2.29 (0.99) |
Group EEG and self-report data pre and post treatment
| Pre-treatment | Post-treatment | Test statistics | |||||
|---|---|---|---|---|---|---|---|
| ( | ( | Wilcoxon | |||||
| Somatic self-efficacy | 2.93 | (0.91) | 3.79 | (0.81) | 6.5 | .58 | |
| EEG high beta % | 4.68 | (2.97) | 3.19 | (1.32) | 130.0 | .32 | |
| EEG low beta % | 7.34 | (4.21) | 6.27 | (2.93) | 114.0 | .115 | .21 |
| EEG SMR % | 7.97 | (3.86) | 8.12 | (3.63) | 83.0 | .466 | .02 |
| EEG alpha % | 13.80 | (6.96) | 15.85 | (6.96) | 53.0 | .084 | .24 |
| EEG theta % | 16.89 | (5.00) | 17.79 | (4.67) | 57.0 | .115 | .21 |
| EEG delta % | 49.32 | (16.43) | 48.80 | (11.87) | 100.0 | .276 | .11 |
| Binge eating episodes | 4.38 | (2.77) | 3.27 | (3.34) | 105.5 | .027* | .33 |
| Somatic self-efficacy | 2.71 | (0.89) | 3.41 | (1.06) | 16.5 | .47 | |
| EEG high beta % | 4.04 | (2.57) | 3.39 | (2.06) | 111.0 | .19 | |
| EEG low beta % | 7.01 | (2.80) | 6.18 | (3.11) | 119.0 | .077 | .24 |
| EEG SMR % | 8.85 | (3.70) | 8.44 | (4.42) | 97.0 | .320 | .08 |
| EEG alpha % | 16.18 | (6.61) | 18.12 | (8.32) | 73.0 | .305 | .09 |
| EEG theta % | 18.39 | (3.64) | 17.62 | (3.19) | 113.0 | .123 | .20 |
| EEG delta % | 45.53 | (10.50) | 46.24 | (13.28) | 87.0 | .483 | .01 |
| Binge eating episodes | 4.50 | (3.84) | 2.83 | (3.49) | 120.0 | .020* | .35 |
Test statistics: within-groups t-tests; p-values: one-sided, * p < .05; ** p < .01. Conventions for effect size r: r ≥ .10 small effect; r ≥ .30 medium effect; r ≥ .50 large effect. For p-values of group-comparisons used for hypothesis testing (H1, bold print) are corrected for multiple comparisons (Holm); p-values of all other exploratory comparisons are reported without corrections for multiple testing
Fig. 2Comparison of post-treatment EEG high beta activity (relative) in participants with or without clinically relevant success (≥ 50% vs. < 50% symptom reduction); Test statistics: Mann–Whitney U-Test, error bars indicate standard errors, *p < .05
Hierarchic regression for the prediction of binge eating episodes after Neurofeedback
| Variable | β | Δ | ||||
|---|---|---|---|---|---|---|
| Constant | − 0.82 | − 0.44 | .699 | [− 4.79; 3.16] | ||
| EEG high beta T1 | 1.29 | .51 | 2.36 | .032 | [0.13; 2.44] | .26 |
| Constant | 5.10 | 1.52 | .149 | [− 2.05; 12.25] | ||
| EEG high beta T1 | 1.41 | .56 | 2.82 | .013 | [0.34; 2.48] | .26 |
| Somatic self-efficacy T1 | − 1.67 | − .41 | − 2.05 | .058 | [− 3.41; 0.07] | .16 |
Y = Binge eating episodes post treatment, n = 18, T1 = post-treatment
Hierarchic regression for the prediction of binge eating episodes after Mental Imagery
| Variable | β | Δ | ||||
|---|---|---|---|---|---|---|
| Constant | 2.44 | 1.46 | .163 | [− 1.09; 5.96] | ||
| EEG high beta T1 | 0.12 | .07 | 0.28 | .785 | [− 0.78; 1.01] | .01 |
| Constant | 9.77 | 3.61 | .003 | [3.99; 15.54] | ||
| EEG high beta T1 | 0.04 | .02 | 0.10 | .920 | [− 0.69; 0.76] | .01 |
| Somatic self-efficacy T1 | − 2.07 | − .63 | − 3.11 | .007 | [− 3.48; − 0.65] | .39 |
Y = Binge eating episodes post treatment, n = 18, T1 = post-treatment